References
Aalberse RC, Dieges PH, Knul-Bretlova V, Vooren P, Aalbers M, et al. IgG4 as a blocking antibody. Clinical Reviews in Allergy 1: 289–302, 1983
Committee on Safety of Medicines. CSM Update: desensitizing vaccines. British Medical Journal 293: 148, 1986
Creticos PS, Van Metre TE, Mardiney MR, Rosenberg GL, Norman PS, et al. Dose response of IgE and IgG antibodies during ragweed immunotherapy. Journal of Allergy and Clinical Immunology 73: 94–104, 1984
Dreborg S, et al. Immunotherapy (hyposensitization) and bronchial asthma. Baillière’s Clinical Immunology and Allergy 2: 245–258, 1988
Editorial. Unproven procedures for diagnosis and treatment of allergic and immunologic diseases. Position statement by the Executive Committee of the American Academy of Allergy and Immunology. Journal of Allergy and Clinical Immunology 78: 275, 1986
Ford RPK, Dawson KP. Is there a place for bee venom desensitization in children? Australian and New Zealand Journal of Medicine 17: 85, 1987
Golden DBK, Langlois J, Valentine MD, et al. Treatment failures with whole body extract therapy of insect sting allergy. Journal of the American Medical Association 246: 2460, 1981
Golden DBK, Schwartz HJ. Guidelines for venom immunotherapy. Journal of Allergy and Clinical Immunology 77: 727, 1986
Grant WB, et al. Does immunotherapy have a role in the treatment of asthma? Clinical Allergy 16: 7–10, 1986
Grieco MH. Diagnosis of upper respiratory tract allergy: classical versus controversial. Immunology and Allergy Clinics of North America 7: 1, 1987
Lichtenstein LM, et al. Insect allergy: the state of the art. Journal of Allergy and Clinical Immunology 64: 5, 1979
Lichtenstein LM, MacGlashan DW. The concept of basophil releasability. Journal of Allergy and Clinical Immunology 77: 291–294, 1986
Lichtenstein LM, Norman PS, Winkenwerder WL, Osier AG. In vitro studies of human ragweed allergy: changes in cellular and humoralactivity associated with specific desensitization. Journal of Clinical Investigation 45: 1126, 1966
Lockey RF, et al. Fatalities from immunotherapy and skin testing. Journal of Allergy and Clinical Immunology 79: 660, 1987
Mailing H-J (Ed.) Immunotherapy. Position paper prepared by the Immunotherapy Subcommittee of the European Academy of Allergology and Clinical Immunology. Allergy 43 (Suppl. 6), 1988
Noon L. Prophylactic innoculation against hay fever. Lancet 1: 1572–1573, 1911
Nordic Council on Medicines. Registration of Allergen Preparations: Nordic Guidelines, 2nd ed., Uppsala, 1989
Norman PS. Why standardized extracts? Journal of Allergy and Clinical Immunology 77: 405, 1985
Norman PS, Van Metre TE. The safety of allergenic immunotherapy. Journal of Allergy and Clinical Immunology 85(2): 522–525, 1990
Platts-Mills TAE, Chapman MD. Dust mites: immunology, allergic disease, and environmental control. Journal of Allergy and Clinical Immunology 80: 755, 1987
Schaeffer M, Sisk LC. Allergenic extracts: a review of their safety and efficacy. Annals of Allergy 52: 2, 1984
Tamir R, Castracane JM, Rocklin RE. Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis. Journal of Allergy and Clinical Immunology 79: 591–598, 1987
Thompson RA, et al. Current status of allergen immunotherapy: shortened version of a World Health Organization/International Union of Immunological Societies working group report. Lancet 1: 259, 1989
Urbanek R, Kemeny DM, Richards D. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clinical Allergy 16: 317–322, 1986
US Department of Health and Human Services, Food and Drug Administration. Biological products; allergenic extracts; implementations of efficacy review; proposed rule. Federal Register Pt II, 50: 3082, 1985
Van Metre TE, Adkinson NF. Immunotherapy for aeroallergen disease. In Middleton et al. (Eds) Allergy: principles and practice, 2nd ed., pp. 1327–1343, CV Mosby Co, St Louis, 1988
Warner JO, Kerr JW. Hyposensitization. British Medical Journal 294: 1179, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loblay, R.H. Allergen Immunotherapy. Drugs 40, 493–497 (1990). https://doi.org/10.2165/00003495-199040040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199040040-00002